Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Bouchardy J"'
Autor:
Yang, Hayang, Bouma, Berto J., Mulder, Barbara J M, Heidendael, J. F., Veen, G., Konings, Thelma C, Sieswerda, G. T.J., Meijboom, F. J., Post, M. C., van Dijk, A., Budts, W., Morissens, M., Ladouceur-Wodzak, Michelle, Tobler, D., Schwerzmann, M., Rutz, T., Bouchardy, J., Greutmann, M., Scognamiglio, G., Skoglund, K., Christersson, C., Gumbiene, L., Laukyte, M., Khairy, P., Aboulhosn, J., Veldtman, G., Webb, G., Broberg, C. S., Opotowsky, A. R., Shafer, K., Tsai, S. F., Moe, T., Niwa, K., Mizuno, A.
Publikováno v:
Cardiovascular Drugs and Therapy
Cardiovascular Drugs and Therapy, 31(4), 413-417. Kluwer Academic Publishers
Cardiovascular drugs and therapy, Dordrecht, Springer, 2017, Vol. 31, no 4, p. 413-417
Yang, H, Bouma, B J, Mulder, B J M, Veen, G, Konings, T C & On behalf of The Non vitamin K antagonist Oral anticoagulants for ThromboEmbolic prevention in adult congenital heart disease (NOTE) investigators 2017, ' Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease? ', Cardiovascular Drugs and Therapy, vol. 31, no. 4, pp. 413-417 . https://doi.org/10.1007/s10557-017-6745-y
Cardiovascular Drugs and Therapy, 31(4), 413. Kluwer Academic Publishers
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 31(4), 413-417. Kluwer Academic Publishers
Cardiovascular Drugs and Therapy, 31(4), 413-417. Kluwer Academic Publishers
Cardiovascular drugs and therapy, Dordrecht, Springer, 2017, Vol. 31, no 4, p. 413-417
Yang, H, Bouma, B J, Mulder, B J M, Veen, G, Konings, T C & On behalf of The Non vitamin K antagonist Oral anticoagulants for ThromboEmbolic prevention in adult congenital heart disease (NOTE) investigators 2017, ' Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease? ', Cardiovascular Drugs and Therapy, vol. 31, no. 4, pp. 413-417 . https://doi.org/10.1007/s10557-017-6745-y
Cardiovascular Drugs and Therapy, 31(4), 413. Kluwer Academic Publishers
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 31(4), 413-417. Kluwer Academic Publishers
Background In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly prescribed to adults with congenital heart disease (CHD) and atrial arrhythmias without good evidence for either safety or efficacy. To addr